182 results on '"Frustaci, Andrea"'
Search Results
2. Long‐Term Clinical‐Pathologic Results of Enzyme Replacement Therapy in Prehypertrophic Fabry Disease Cardiomyopathy
3. Novel ATP2A2 Gene Mutation c.118G>A Causing Keratinocyte and Cardiomyocyte Disconnection in Darier Disease
4. Cardiomyocyte Regeneration in Human Myocarditis
5. Fabry Cardiomyopathy: Myocardial Fibrosis, Inflammation and Down-Regulation of Mannose6Phosphate Receptors cause Low accessibility to Enzyme Replacement Therapy
6. Pathogenic contribute of unaffected cardiac cells in female Fabry cardiomyopathy
7. Novel Genetic Microvascular Dysplasia Causing Hypoperfusion of Cardiac, Renal, and Cerebral Circulation
8. Host-microbe tryptophan partitioning in cardiovascular diseases
9. Novel Genetic Systemic Obstructive Microvascular Dysplasia
10. Immunosuppressive Therapy in Myocarditis: Lessons from Clinical Trials and Future Perspectives
11. Endomyocardial Biopsy
12. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy
13. Circulating Anti-GB3 Antibody as a Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy
14. Interleukin 17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery Following Secukinumab Administration
15. Circulating Anti-GB3 Antibody as Biomarker of Myocardial Inflammation in Patients with Fabry Disease Cardiomyopathy
16. Infiltration of Conduction Tissue Is a Major Cause of Electrical Instability in Cardiac Amyloidosis
17. Prednisone administration in inflammatory cardiomyopathy: caveat for potentially adverse myocardial actions
18. Interleukin 17A-Correlated Myocarditis in Patients with Psoriasis: Cardiac Recovery Following Secukinumab Administration
19. Remarks on Myocarditis Associated with COVID-19 Infection and Myocarditis Following mRNA COVID-19 Vaccination
20. Individualized immunosuppression in virus-negative inflammatory cardiomyopathy
21. Myocarditis followingCOVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases
22. Downregulation of Mannose-6-Phosphate Receptors in Fabry Disease Cardiomyopathy: A Potential Target for Enzyme Therapy Enhancement
23. Removal of cardiac AL amyloid with positive remodelling of cardiomyocytes and of restrictive cardiomyopathy
24. COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review
25. Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial
26. Hypersensitivity Myocarditis after COVID-19 mRNA Vaccination
27. Prevalence and Clinical Implications of COVID-19 Myocarditis
28. Divergent Impact of Enzyme Replacement Therapy on Human Cardiomyocytes and Enterocytes Affected by Fabry Disease: Correlation with Mannose-6-phosphate Receptor Expression
29. New Insights in Human Myocarditis
30. Hypersensitivity Myocarditis Following Deferasirox Administration
31. A proposed strategy for anticoagulation therapy in noncompaction cardiomyopathy
32. Myocardial Aldosterone Receptor and Aquaporin 1 Up-Regulation Is Associated with Cardiomyocyte Remodeling in Human Heart Failure
33. Pemphigus‐associated cardiomyopathy: report of autoimmune myocarditis and review of literature
34. Virus-Negative Necrotizing Coronary Vasculitis with Aneurysm Formation in Human SARS-CoV-2 Infection
35. False‐positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy
36. Hypertrophy of unaffected cardiomyocytes correlates with severity of cardiomyopathy in female patients with Fabry disease
37. Novel dilated cardiomyopathy associated to Calreticulin and Myo7A gene mutation in Usher syndrome
38. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital
39. Strengths and Limitations of the Evidence-Based Movement Aimed to Improve Clinical Outcomes in Dentistry and Oral Surgery
40. Immunosuppressive treatment of inflammatory cardiomyopathy patients
41. Myocarditis-associated necrotizing coronary vasculitis: incidence, cause, and outcome
42. 447 Pathology of conduction tissue in cardiac amyloid: correlation with arrhythmic manifestations
43. Use of the new Lake Louise Criteria improves CMR detection of atypical forms of acute myocarditis
44. Inflammation of Conduction Tissue in Patients with Arrhythmic Phenotype of Myocarditis
45. Myocarditis and intramural coronary vasculitis in polyarteritis nodosa: an unusual treatable form of heart failure
46. Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative
47. Cardiomyopathies and Adrenal Diseases
48. Kappa-light Chain Amyloid Overlapping Hypertrophic Cardiomyopathy With Myocardial Noncompaction
49. Fabry cardiomyopathy: Gb3‐induced auto‐reactive panmyocarditis requiring heart transplantation
50. Undiagnosed Fabry disease: the importance of screening for Fabry disease before transcutaneous patent foramen ovale closure in a young patient with cryptogenic stroke
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.